• M Hünerbein, S Gretschel, B Rau, and P M Schlag.
• Klinik für Chirurgie und Chirurgische Onkologie, Charité, Campus Berlin-Buch, Robert-Rössle-Klinik im Helios-Klinikum Berlin.
• Chirurg. 2003 Apr 1; 74 (4): 282-9.

AbstractMinimally invasive surgery has become a viable alternative to conventional surgery. The technical advantages of minimally invasive surgery can be translated into clinical benefits for the patients, i.e., less postoperative pain and impairment of lung function, better cosmetic results, shorter hospitalization, and earlier convalescence. Laparoscopic operations have replaced a significant proportion of open surgical procedures and are now routinely used. While the role of laparoscopic surgery has been generally accepted for the management of benign disorders, there is ongoing debate regarding the adequacy of this technique in surgical oncology. There is evidence that minimally invasive surgery can reduce perioperative morbidity in cancer patients. However, definite validation of these procedures for tumor surgery is not yet available due to the lack of prospective randomized trials providing reliable long-term data on disease-free survival and overall survival. It seems likely that minimally invasive procedures will play an important role for the treatment of preneoplastic lesions and tumors of limited size.

17 keywords...

hide…